Published

Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Molecular psychiatry
Date: 2026-07-09
Source: PubMed
DOI: 10.1038/s41380-026-03744-8
PubMed: 42432011

Authors

Lin C Wang X

Watch author

Derived topics and classifications

psilocybin Neuroplasticity Mechanism of Action Receptor Pharmacology Epigenetics Mitochondrial Function Review Article Transcriptomics Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open Science Framework · 2026-07-08 Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challengesJournal of Psychiatric Research · 2026-06-22 Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive UseJournal of Advances in Developmental Research · 2026-06-17 THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14 Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for CliniciansDrugs · 2026-06-03 Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.International Journal of Eating Disorders · 2026-07-01 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31 Classic psychedelics and personality: An updated systematic reviewJournal of Psychopharmacology · 2026-05-30